# Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens

> **NCT02191319** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 55 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Viramune®

## Key facts

- **NCT ID:** NCT02191319
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2004-08
- **Final completion:** —
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2014-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02191319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02191319, "Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02191319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*